Slater E E, Haber E
J Clin Endocrinol Metab. 1978 Jul;47(1):105-9. doi: 10.1210/jcem-47-1-105.
The apparent molecular size of circulating human plasma renin is 43,000 daltons. In this report, the Stokes' radius of renin extracted from human kidney cortex in low ionic strength buffer in the presence of protease inhibitors was shown to correspond to an apparent molecular weight of 58,000 +/- 3,000. If protease inhibitors are omitted, if the kidney tissue is frozen and thawed multiple times, or if the kidney extract is acidified to pH 2.8, renin activity of an apparent molecular size of 42,000 +/- 3,000 can be identified. Both species of renin bind to an affinity support bearing the substrate analog inhibitor His-Pro-Phe-His-Leu-D-Leu-Val-Tyr. Antibody raised to the higher molecular form of the enzyme inhibits the activity of both forms in an equivalent manner. These observations suggest that the larger form of renin may be a biosynthetic precursor of plasma renin, either in the form of a zymogen or an enzyme-binding protein complex.
循环中的人血浆肾素的表观分子大小为43,000道尔顿。在本报告中,在蛋白酶抑制剂存在的情况下,从人肾皮质中以低离子强度缓冲液提取的肾素的斯托克斯半径显示对应于58,000±3,000的表观分子量。如果省略蛋白酶抑制剂,如果肾脏组织多次冷冻和解冻,或者如果将肾脏提取物酸化至pH 2.8,则可以鉴定出表观分子大小为42,000±3,000的肾素活性。两种肾素都与带有底物类似物抑制剂His-Pro-Phe-His-Leu-D-Leu-Val-Tyr的亲和支持物结合。针对该酶的较高分子形式产生的抗体以同等方式抑制两种形式的活性。这些观察结果表明,较大形式的肾素可能是血浆肾素的生物合成前体,其形式为酶原或酶结合蛋白复合物。